Astellas Gene Therapies in den Nachrichten
Entwicklung genetischer Medikamente
Tamtam hat 15 aktuelle Artikel über Astellas Gene Therapies gefunden.
- A Gene-Therapy Pioneer Just Filed For Chapter 11 Bankruptcy—Now Eli Lilly Wants Its Tech
- UPDATE: Lilly, Astellas circle Sangamo assets as biotech files for bankruptcy
- Report details damage to sensory nerve cells with Pompe gene therapy in case
- Astellas retries XLMTM gene therapy after deaths
- Astellas Licenses Dyno Therapeutics’ AI-Designed AAV Capsid, Advancing Gene Delivery for Muscle Disorders
- Astellas unearths Dyno muscle disorder AAV capsid with $15M option agreement
- Astellas Takes Aim at XLMTM Again, Now with MyoAAV Capsid-Based Gene Therapy
- Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More
- Astellas Gene Therapies to Close Biomanufacturing Facility, Affecting About 100 Employees
- In analysis of gene therapy deaths, Astellas points to underlying liver issues
- Staying the Course: New CEO, Same Focus for Astellas Gene Therapies
- Astellas, despite recent setbacks, opens $100M gene therapy plant
- Astellas Celebrates the Opening of Its New Large-Scale Gene Therapy Manufacturing Facility in North Carolina
- Fourth trial volunteer dies in Astellas gene therapy study
- Audentes Therapeutics Expands Mission, Becomes Astellas Gene Therapies
Von Tamtam gesammelte Artikel, die sich auf das Unternehmen beziehen, die neuesten zuerst. Jeder verlinkt auf seine Quelle.
Sie verkaufen an Unternehmen wie Astellas Gene Therapies?
Tamtam findet die Unternehmen, die zu Ihrem idealen Kunden passen, recherchiert jeden Account und sagt Ihnen, wen Sie wann kontaktieren sollten.
Ähnliche Unternehmen finden